Top Markets
Coin of the day
Hubei Biocause Heilen Pharmaceutical Co., Ltd. Hubei Biocause Heilen Pharmaceutical Co., Ltd.

Hubei Biocause Heilen Pharmaceutical Co., Ltd.

301211
Rank in Stocks #10977
Hubei Biocause Heilen Pharmaceutical Co., Ltd. is a Chinese enterprise with... Hubei Biocause Heilen Pharmaceutical Co., Ltd. is a Chinese enterprise with diverse operations spanning the pharmaceutical, chemical, and new energy fuel sectors. Within its pharmaceutical segment, the company manufactures active pharmaceutical ingredients (APIs), various intermediates, and finished drug formulations. Furthermore, its chemical offerings include industrial products such as dimethyl ether gas and chloropropionyl chloride. The firm is headquartered in Jingmen, China.
Share Price
$1.82
Last synced: 2026-08-28
Market Cap
$760.08M
Change (1 day)
-3.16%
Change (1 year)
3.42%
Country
CN
Trade Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211)

Category

Revenue for Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211)
Revenue in Aug 2026 TTM: 0
According to Hubei Biocause Heilen Pharmaceutical Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Hubei Biocause Heilen Pharmaceutical Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors